ProductProductWhat are Generics?
Vytorin
view photo
Generic Vytorin Simvastatin Ezetimibe 10mg + 10/20mg + 10mg

Generic Vytorin is used for treating high cholesterol along with a cholesterol-lowering diet. It works by reducing the amount of cholesterol that your body absorbs from your meals. Lowering cholesterol levels in the blood reduces the chance of heart disease, heart attacks and strokes.


Cholesterol


PackagePricePer pillSavingsOrder
10mg + 10mg × 30 pills$78.20$ 2.61 
10mg + 10mg × 60 pills$146.40$ 2.44  $10.00
10mg + 10mg × 90 pills$198.60$ 2.21  $36.00
10mg + 10mg × 120 pills$250.80$ 2.09  $62.00
PackagePricePer pillSavingsOrder
20mg + 10mg × 30 pills$110.40$ 3.68 
20mg + 10mg × 60 pills$214.80$ 3.58  $6.00
20mg + 10mg × 90 pills$301.20$ 3.35  $30.00
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
Thank you for your follow up, I did receive the pills and had an opportunity to try them. I am very happy, so is my girlfriend.
Thanks - DN
Read more »Read more »
NewsNews
    Did FDA's Vytorin warning negatively impact health outcomes? - Medical Marketing and Media
    Did FDA's Vytorin warning negatively impact health outcomes?Medical Marketing and MediaResearchers keyed in on an FDA communication to clinicians issued January 25, 2008, regarding ezetimibe (known as either Zetia or the ezetimibe-simvastatin combination, Vytorin)
    Merck Wins Two Patent Lawsuits - New York Times
    Merck Wins Two Patent LawsuitsNew York TimesWHITEHOUSE STATION, NJ (AP) — Merck & Company says it won two patent infringement lawsuits against Mylan Pharmaceuticals, a leading generic drug maker, which is seeking to make generic versions of Merck's lucrative cholesterol pills, Zetia and Vytorin
    Study: Docs barring pharma reps has unexpected side effects - FiercePharma
    Study: Docs barring pharma reps has unexpected side effectsFiercePharmaThese low-access doctors were not significantly slower, however, when it came to changing their prescribing habits after a study questioned the efficacy of Merck's combination cholesterol drug Vytorin
    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks; - FiercePharma
    Merck wins patent fight on Zetia, Vytorin; Fitch warns of 'pure pharma' risks;FiercePharmaArticle | Follow @FiercePharma > A US court upheld Merck's ($MRK) patent on the active ingredient ezetimibe, marketed as the cholesterol-lowering Zetia and in the combo cholesterol pill Vytorin
    CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate ... - MarketWatch (press release)
    CVS Caremark Sponsored Research Finds FDA Drug Warnings Can Have Immediate
Live support Online Chat


Our billing is certified by
Secure shopping certificates